The Pandemic's Impact on Venture Capital - Dr Simon Barnes

WTFinance are happy to welcome Dr Simon Barnes as our second podcast guest.

Dr Barnes career began in academia and research, completing a bachelors and PhD at Cambridge University in Plant Molecular Biology and Bio Chemistry, undertaking a NATO Research Fellowship at Rockefeller University in New York and was Head of the Laboratory of Cotton Biotechnology in Singapore. He then pivoted to start a career in Venture Capital, looking to commercialise the scientific advancements he was seeing first hand. He studied an MBA at Imperial College London and later was Director of Imperial's Entrepreneurship Centre where he co-authored "Raising Venture Capital".

He has since worked at Atlas Ventures, Gimv and has co-founded Circadia Ventures, raising £55 million under management on behalf of Tate & Lyle. This has led to him investing in and being a Director of Evolve Biosystems, Changing Health and Prolypin GmbH. 

Simon talks about his career in Venture Capital, advice on people looking to pursue a career in VC and thoughts on the landscape of VC now and into the future.

If you have any questions or want to get in contact with Simon - Simon.Barnes@wbs.ac.uk 

WTFinance Platforms -
Instagram - https://www.instagram.com/wtfinancee/
Youtube - https://www.youtube.com/channel/UCPI-DJWmId3Y-Dd1yI8LDnw